Li Jie, Director of Shenzhen Guanlan Customs, And His Entourage Visited Hybio Pharmaceutical to Conduct Research and Assist the Company in Its New Development

Li Jie, Director of Shenzhen Guanlan Customs, led a delegation to visit Hybio Pharmaceutical for an inspection, with the aim of supporting the company's new development initiatives

On April 21, 2025, a research team led by Li Jie, Director of Shenzhen Guanlan Customs, paid a visit to Hybio Pharmaceutical for investigation. Mr. Zeng Shaogui, Chairman and President of Hybio Pharmaceutical, Mr. Tu Honghong, Vice President and Chief Financial Officer, as well as heads of relevant business departments accompanied the research team throughout the visit and participated in the symposium.

At the symposium, the management of Hybio Pharmaceutical reported to the customs research team on issues such as the company's international business development and cross-border transportation plans, and expressed gratitude for the long-term support from Shenzhen Guanlan Customs. The visit team listened to the company's demands and answered some policy questions on site.

This visit will help open up communication channels between customs and businesses, and provide assistance for customs to support business development and solve business problems in the future. Taking this opportunity, Hybio Pharmaceutical will optimize its international business layout in combination with the current development situation and promote the sustainable development of the enterprise.